ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nanotechnology in Cancer Treatment Market Insights, Forecast to 2028
Published Date: March 2022
|
Report Code: QYRE-Auto-16U5860
Home | Market Reports | Health| Nursing
Global Nanotechnology in Cancer Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Nanotechnology in Cancer Treatment Market Insights, Forecast to 2028

Code: QYRE-Auto-16U5860
Report
March 2022
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
CombiMatrix Corporation
GE Healthcare
Sigma tau pharmaceuticals Inc.
Johnson & Johnson
Mallinckrodt plc
Merck& Company Inc.
Nanosphere
Pfizer Inc
Celgene Corporation

Nanotechnology in Cancer Treatment Market Insights - 2028

The global Nanotechnology in Cancer Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Nanoparticles accounting for % of the Nanotechnology in Cancer Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Cancer Detection segment is altered to an % CAGR throughout this forecast period.

China Nanotechnology in Cancer Treatment market size is valued at US$ million in 2021, while the North America and Europe Nanotechnology in Cancer Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Nanotechnology in Cancer Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nanotechnology in Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nanotechnology in Cancer Treatment market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nanotechnology in Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nanotechnology in Cancer Treatment market.

Nanotechnology in Cancer Treatment Market Scope and Market Size

Nanotechnology in Cancer Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Nanotechnology in Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment By Type 

  • Nanorods
  • Nanofibers
  • Graphene
  • Metal-Organic Frameworks
  • Nanobiosensors
  • Nanofluidic Devices
  • Nanotools

Segment By Application

  • Cancer Detection
  • Imaging
  • Drug Delivery
  • Radiotherapy
  • Immunotherapy
  • Phototherapy

By Company

  • Abbott Laboratories
  • Combimatrix Corporation
  • GE Healthcare
  • Sigma-Tau Pharmaceuticals Inc.
  • Johnson & Johnson
  • Mallinckrodt Plc
  • Merck & Company Inc.
  • Nanosphere Inc.
  • Pfizer, Inc.
  • Celgene Corporation

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanotechnology in Cancer Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Nanoparticles
1.2.3 Nanorods
1.2.4 Nanofibers
1.2.5 Graphene
1.2.6 Metal-Organic Frameworks
1.2.7 Nanobiosensors
1.2.8 Nanofluidic Devices
1.2.9 Nanotools
1.3 Market by Application
1.3.1 Global Nanotechnology in Cancer Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer Detection
1.3.3 Imaging
1.3.4 Drug Delivery
1.3.5 Radiotherapy
1.3.6 Immunotherapy
1.3.7 Phototherapy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nanotechnology in Cancer Treatment Market Perspective (2017-2028)
2.2 Nanotechnology in Cancer Treatment Growth Trends by Region
2.2.1 Nanotechnology in Cancer Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nanotechnology in Cancer Treatment Historic Market Size by Region (2017-2022)
2.2.3 Nanotechnology in Cancer Treatment Forecasted Market Size by Region (2023-2028)
2.3 Nanotechnology in Cancer Treatment Market Dynamics
2.3.1 Nanotechnology in Cancer Treatment Industry Trends
2.3.2 Nanotechnology in Cancer Treatment Market Drivers
2.3.3 Nanotechnology in Cancer Treatment Market Challenges
2.3.4 Nanotechnology in Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanotechnology in Cancer Treatment Players by Revenue
3.1.1 Global Top Nanotechnology in Cancer Treatment Players by Revenue (2017-2022)
3.1.2 Global Nanotechnology in Cancer Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Nanotechnology in Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanotechnology in Cancer Treatment Revenue
3.4 Global Nanotechnology in Cancer Treatment Market Concentration Ratio
3.4.1 Global Nanotechnology in Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanotechnology in Cancer Treatment Revenue in 2021
3.5 Nanotechnology in Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Nanotechnology in Cancer Treatment Product Solution and Service
3.7 Date of Enter into Nanotechnology in Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanotechnology in Cancer Treatment Breakdown Data by Type
4.1 Global Nanotechnology in Cancer Treatment Historic Market Size by Type (2017-2022)
4.2 Global Nanotechnology in Cancer Treatment Forecasted Market Size by Type (2023-2028)
5 Nanotechnology in Cancer Treatment Breakdown Data by Application
5.1 Global Nanotechnology in Cancer Treatment Historic Market Size by Application (2017-2022)
5.2 Global Nanotechnology in Cancer Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nanotechnology in Cancer Treatment Market Size (2017-2028)
6.2 North America Nanotechnology in Cancer Treatment Market Size by Type
6.2.1 North America Nanotechnology in Cancer Treatment Market Size by Type (2017-2022)
6.2.2 North America Nanotechnology in Cancer Treatment Market Size by Type (2023-2028)
6.2.3 North America Nanotechnology in Cancer Treatment Market Share by Type (2017-2028)
6.3 North America Nanotechnology in Cancer Treatment Market Size by Application
6.3.1 North America Nanotechnology in Cancer Treatment Market Size by Application (2017-2022)
6.3.2 North America Nanotechnology in Cancer Treatment Market Size by Application (2023-2028)
6.3.3 North America Nanotechnology in Cancer Treatment Market Share by Application (2017-2028)
6.4 North America Nanotechnology in Cancer Treatment Market Size by Country
6.4.1 North America Nanotechnology in Cancer Treatment Market Size by Country (2017-2022)
6.4.2 North America Nanotechnology in Cancer Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Nanotechnology in Cancer Treatment Market Size (2017-2028)
7.2 Europe Nanotechnology in Cancer Treatment Market Size by Type
7.2.1 Europe Nanotechnology in Cancer Treatment Market Size by Type (2017-2022)
7.2.2 Europe Nanotechnology in Cancer Treatment Market Size by Type (2023-2028)
7.2.3 Europe Nanotechnology in Cancer Treatment Market Share by Type (2017-2028)
7.3 Europe Nanotechnology in Cancer Treatment Market Size by Application
7.3.1 Europe Nanotechnology in Cancer Treatment Market Size by Application (2017-2022)
7.3.2 Europe Nanotechnology in Cancer Treatment Market Size by Application (2023-2028)
7.3.3 Europe Nanotechnology in Cancer Treatment Market Share by Application (2017-2028)
7.4 Europe Nanotechnology in Cancer Treatment Market Size by Country
7.4.1 Europe Nanotechnology in Cancer Treatment Market Size by Country (2017-2022)
7.4.2 Europe Nanotechnology in Cancer Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanotechnology in Cancer Treatment Market Size (2017-2028)
8.2 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Nanotechnology in Cancer Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Nanotechnology in Cancer Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nanotechnology in Cancer Treatment Market Size (2017-2028)
9.2 Latin America Nanotechnology in Cancer Treatment Market Size by Type
9.2.1 Latin America Nanotechnology in Cancer Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Nanotechnology in Cancer Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Nanotechnology in Cancer Treatment Market Share by Type (2017-2028)
9.3 Latin America Nanotechnology in Cancer Treatment Market Size by Application
9.3.1 Latin America Nanotechnology in Cancer Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Nanotechnology in Cancer Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Nanotechnology in Cancer Treatment Market Share by Application (2017-2028)
9.4 Latin America Nanotechnology in Cancer Treatment Market Size by Country
9.4.1 Latin America Nanotechnology in Cancer Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Nanotechnology in Cancer Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanotechnology in Cancer Treatment Market Size (2017-2028)
10.2 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Nanotechnology in Cancer Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Nanotechnology in Cancer Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Nanotechnology in Cancer Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Nanotechnology in Cancer Treatment Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 Combimatrix Corporation
11.2.1 Combimatrix Corporation Company Details
11.2.2 Combimatrix Corporation Business Overview
11.2.3 Combimatrix Corporation Nanotechnology in Cancer Treatment Introduction
11.2.4 Combimatrix Corporation Revenue in Nanotechnology in Cancer Treatment Business (2017-2022)
11.2.5 Combimatrix Corporation Recent Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Nanotechnology in Cancer Treatment Introduction
11.3.4 GE Healthcare Revenue in Nanotechnology in Cancer Treatment Business (2017-2022)
11.3.5 GE Healthcare Recent Developments
11.4 Sigma-Tau Pharmaceuticals Inc.
11.4.1 Sigma-Tau Pharmaceuticals Inc. Company Details
11.4.2 Sigma-Tau Pharmaceuticals Inc. Business Overview
11.4.3 Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Introduction
11.4.4 Sigma-Tau Pharmaceuticals Inc. Revenue in Nanotechnology in Cancer Treatment Business (2017-2022)
11.4.5 Sigma-Tau Pharmaceuticals Inc. Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Nanotechnology in Cancer Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Nanotechnology in Cancer Treatment Business (2017-2022)
11.5.5 Johnson & Johnson Recent Developments
11.6 Mallinckrodt Plc
11.6.1 Mallinckrodt Plc Company Details
11.6.2 Mallinckrodt Plc Business Overview
11.6.3 Mallinckrodt Plc Nanotechnology in Cancer Treatment Introduction
11.6.4 Mallinckrodt Plc Revenue in Nanotechnology in Cancer Treatment Business (2017-2022)
11.6.5 Mallinckrodt Plc Recent Developments
11.7 Merck & Company Inc.
11.7.1 Merck & Company Inc. Company Details
11.7.2 Merck & Company Inc. Business Overview
11.7.3 Merck & Company Inc. Nanotechnology in Cancer Treatment Introduction
11.7.4 Merck & Company Inc. Revenue in Nanotechnology in Cancer Treatment Business (2017-2022)
11.7.5 Merck & Company Inc. Recent Developments
11.8 Nanosphere Inc.
11.8.1 Nanosphere Inc. Company Details
11.8.2 Nanosphere Inc. Business Overview
11.8.3 Nanosphere Inc. Nanotechnology in Cancer Treatment Introduction
11.8.4 Nanosphere Inc. Revenue in Nanotechnology in Cancer Treatment Business (2017-2022)
11.8.5 Nanosphere Inc. Recent Developments
11.9 Pfizer, Inc.
11.9.1 Pfizer, Inc. Company Details
11.9.2 Pfizer, Inc. Business Overview
11.9.3 Pfizer, Inc. Nanotechnology in Cancer Treatment Introduction
11.9.4 Pfizer, Inc. Revenue in Nanotechnology in Cancer Treatment Business (2017-2022)
11.9.5 Pfizer, Inc. Recent Developments
11.10 Celgene Corporation
11.10.1 Celgene Corporation Company Details
11.10.2 Celgene Corporation Business Overview
11.10.3 Celgene Corporation Nanotechnology in Cancer Treatment Introduction
11.10.4 Celgene Corporation Revenue in Nanotechnology in Cancer Treatment Business (2017-2022)
11.10.5 Celgene Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
CombiMatrix Corporation
GE Healthcare
Sigma tau pharmaceuticals Inc.
Johnson & Johnson
Mallinckrodt plc
Merck& Company Inc.
Nanosphere
Pfizer Inc
Celgene Corporation
List of Tables
    Table 1. Global Nanotechnology in Cancer Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Nanoparticles
    Table 3. Key Players of Nanorods
    Table 4. Key Players of Nanofibers
    Table 5. Key Players of Graphene
    Table 6. Key Players of Metal-Organic Frameworks
    Table 7. Key Players of Nanobiosensors
    Table 8. Key Players of Nanofluidic Devices
    Table 9. Key Players of Nanotools
    Table 10. Global Nanotechnology in Cancer Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 11. Global Nanotechnology in Cancer Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 12. Global Nanotechnology in Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 13. Global Nanotechnology in Cancer Treatment Market Share by Region (2017-2022)
    Table 14. Global Nanotechnology in Cancer Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 15. Global Nanotechnology in Cancer Treatment Market Share by Region (2023-2028)
    Table 16. Nanotechnology in Cancer Treatment Market Trends
    Table 17. Nanotechnology in Cancer Treatment Market Drivers
    Table 18. Nanotechnology in Cancer Treatment Market Challenges
    Table 19. Nanotechnology in Cancer Treatment Market Restraints
    Table 20. Global Nanotechnology in Cancer Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 21. Global Nanotechnology in Cancer Treatment Revenue Share by Players (2017-2022)
    Table 22. Global Top Nanotechnology in Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanotechnology in Cancer Treatment as of 2021)
    Table 23. Ranking of Global Top Nanotechnology in Cancer Treatment Companies by Revenue (US$ Million) in 2021
    Table 24. Global 5 Largest Players Market Share by Nanotechnology in Cancer Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Nanotechnology in Cancer Treatment Product Solution and Service
    Table 27. Date of Enter into Nanotechnology in Cancer Treatment Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Nanotechnology in Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 30. Global Nanotechnology in Cancer Treatment Revenue Market Share by Type (2017-2022)
    Table 31. Global Nanotechnology in Cancer Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 32. Global Nanotechnology in Cancer Treatment Revenue Market Share by Type (2023-2028)
    Table 33. Global Nanotechnology in Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 34. Global Nanotechnology in Cancer Treatment Revenue Share by Application (2017-2022)
    Table 35. Global Nanotechnology in Cancer Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 36. Global Nanotechnology in Cancer Treatment Revenue Share by Application (2023-2028)
    Table 37. North America Nanotechnology in Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 38. North America Nanotechnology in Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 39. North America Nanotechnology in Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 40. North America Nanotechnology in Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 41. North America Nanotechnology in Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 42. North America Nanotechnology in Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Europe Nanotechnology in Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Europe Nanotechnology in Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Europe Nanotechnology in Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Europe Nanotechnology in Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Europe Nanotechnology in Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 48. Europe Nanotechnology in Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Nanotechnology in Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Nanotechnology in Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Nanotechnology in Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Nanotechnology in Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Asia Pacific Nanotechnology in Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 54. Asia Pacific Nanotechnology in Cancer Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 55. Latin America Nanotechnology in Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Latin America Nanotechnology in Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Latin America Nanotechnology in Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Latin America Nanotechnology in Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Latin America Nanotechnology in Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Latin America Nanotechnology in Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Nanotechnology in Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Nanotechnology in Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Nanotechnology in Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Nanotechnology in Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 65. Middle East and Africa Nanotechnology in Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 66. Middle East and Africa Nanotechnology in Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 67. Abbott Laboratories Company Details
    Table 68. Abbott Laboratories Business Overview
    Table 69. Abbott Laboratories Nanotechnology in Cancer Treatment Product
    Table 70. Abbott Laboratories Revenue in Nanotechnology in Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 71. Abbott Laboratories Recent Developments
    Table 72. Combimatrix Corporation Company Details
    Table 73. Combimatrix Corporation Business Overview
    Table 74. Combimatrix Corporation Nanotechnology in Cancer Treatment Product
    Table 75. Combimatrix Corporation Revenue in Nanotechnology in Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 76. Combimatrix Corporation Recent Developments
    Table 77. GE Healthcare Company Details
    Table 78. GE Healthcare Business Overview
    Table 79. GE Healthcare Nanotechnology in Cancer Treatment Product
    Table 80. GE Healthcare Revenue in Nanotechnology in Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 81. GE Healthcare Recent Developments
    Table 82. Sigma-Tau Pharmaceuticals Inc. Company Details
    Table 83. Sigma-Tau Pharmaceuticals Inc. Business Overview
    Table 84. Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Product
    Table 85. Sigma-Tau Pharmaceuticals Inc. Revenue in Nanotechnology in Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 86. Sigma-Tau Pharmaceuticals Inc. Recent Developments
    Table 87. Johnson & Johnson Company Details
    Table 88. Johnson & Johnson Business Overview
    Table 89. Johnson & Johnson Nanotechnology in Cancer Treatment Product
    Table 90. Johnson & Johnson Revenue in Nanotechnology in Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 91. Johnson & Johnson Recent Developments
    Table 92. Mallinckrodt Plc Company Details
    Table 93. Mallinckrodt Plc Business Overview
    Table 94. Mallinckrodt Plc Nanotechnology in Cancer Treatment Product
    Table 95. Mallinckrodt Plc Revenue in Nanotechnology in Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 96. Mallinckrodt Plc Recent Developments
    Table 97. Merck & Company Inc. Company Details
    Table 98. Merck & Company Inc. Business Overview
    Table 99. Merck & Company Inc. Nanotechnology in Cancer Treatment Product
    Table 100. Merck & Company Inc. Revenue in Nanotechnology in Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 101. Merck & Company Inc. Recent Developments
    Table 102. Nanosphere Inc. Company Details
    Table 103. Nanosphere Inc. Business Overview
    Table 104. Nanosphere Inc. Nanotechnology in Cancer Treatment Product
    Table 105. Nanosphere Inc. Revenue in Nanotechnology in Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 106. Nanosphere Inc. Recent Developments
    Table 107. Pfizer, Inc. Company Details
    Table 108. Pfizer, Inc. Business Overview
    Table 109. Pfizer, Inc. Nanotechnology in Cancer Treatment Product
    Table 110. Pfizer, Inc. Revenue in Nanotechnology in Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 111. Pfizer, Inc. Recent Developments
    Table 112. Celgene Corporation Company Details
    Table 113. Celgene Corporation Business Overview
    Table 114. Celgene Corporation Nanotechnology in Cancer Treatment Product
    Table 115. Celgene Corporation Revenue in Nanotechnology in Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 116. Celgene Corporation Recent Developments
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Nanotechnology in Cancer Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Nanoparticles Features
    Figure 3. Nanorods Features
    Figure 4. Nanofibers Features
    Figure 5. Graphene Features
    Figure 6. Metal-Organic Frameworks Features
    Figure 7. Nanobiosensors Features
    Figure 8. Nanofluidic Devices Features
    Figure 9. Nanotools Features
    Figure 10. Global Nanotechnology in Cancer Treatment Market Share by Application: 2021 VS 2028
    Figure 11. Cancer Detection Case Studies
    Figure 12. Imaging Case Studies
    Figure 13. Drug Delivery Case Studies
    Figure 14. Radiotherapy Case Studies
    Figure 15. Immunotherapy Case Studies
    Figure 16. Phototherapy Case Studies
    Figure 17. Nanotechnology in Cancer Treatment Report Years Considered
    Figure 18. Global Nanotechnology in Cancer Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 19. Global Nanotechnology in Cancer Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 20. Global Nanotechnology in Cancer Treatment Market Share by Region: 2021 VS 2028
    Figure 21. Global Nanotechnology in Cancer Treatment Market Share by Players in 2021
    Figure 22. Global Top Nanotechnology in Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanotechnology in Cancer Treatment as of 2021)
    Figure 23. The Top 10 and 5 Players Market Share by Nanotechnology in Cancer Treatment Revenue in 2021
    Figure 24. North America Nanotechnology in Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. North America Nanotechnology in Cancer Treatment Market Size Market Share by Type (2017-2028)
    Figure 26. North America Nanotechnology in Cancer Treatment Market Size Market Share by Application (2017-2028)
    Figure 27. North America Nanotechnology in Cancer Treatment Market Size Share by Country (2017-2028)
    Figure 28. United States Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Canada Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Europe Nanotechnology in Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 31. Europe Nanotechnology in Cancer Treatment Market Size Market Share by Type (2017-2028)
    Figure 32. Europe Nanotechnology in Cancer Treatment Market Size Market Share by Application (2017-2028)
    Figure 33. Europe Nanotechnology in Cancer Treatment Market Size Share by Country (2017-2028)
    Figure 34. Germany Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. France Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. U.K. Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Italy Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Russia Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Nordic Countries Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Asia-Pacific Nanotechnology in Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 41. Asia Pacific Nanotechnology in Cancer Treatment Market Size Market Share by Type (2017-2028)
    Figure 42. Asia Pacific Nanotechnology in Cancer Treatment Market Size Market Share by Application (2017-2028)
    Figure 43. Asia Pacific Nanotechnology in Cancer Treatment Market Size Share by Region (2017-2028)
    Figure 44. China Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Japan Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. South Korea Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Southeast Asia Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. India Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Australia Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 50. Latin America Nanotechnology in Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Latin America Nanotechnology in Cancer Treatment Market Size Market Share by Type (2017-2028)
    Figure 52. Latin America Nanotechnology in Cancer Treatment Market Size Market Share by Application (2017-2028)
    Figure 53. Latin America Nanotechnology in Cancer Treatment Market Size Share by Country (2017-2028)
    Figure 54. Mexico Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Brazil Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Middle East & Africa Nanotechnology in Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 57. Middle East and Africa Nanotechnology in Cancer Treatment Market Size Market Share by Type (2017-2028)
    Figure 58. Middle East and Africa Nanotechnology in Cancer Treatment Market Size Market Share by Application (2017-2028)
    Figure 59. Middle East and Africa Nanotechnology in Cancer Treatment Market Size Share by Country (2017-2028)
    Figure 60. Turkey Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 61. Saudi Arabia Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 62. UAE Nanotechnology in Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 63. Abbott Laboratories Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2017-2022)
    Figure 64. Combimatrix Corporation Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2017-2022)
    Figure 65. GE Healthcare Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2017-2022)
    Figure 66. Sigma-Tau Pharmaceuticals Inc. Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2017-2022)
    Figure 67. Johnson & Johnson Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2017-2022)
    Figure 68. Mallinckrodt Plc Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2017-2022)
    Figure 69. Merck & Company Inc. Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2017-2022)
    Figure 70. Nanosphere Inc. Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2017-2022)
    Figure 71. Pfizer, Inc. Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2017-2022)
    Figure 72. Celgene Corporation Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2017-2022)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions